Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Extranodal NK/T cell lymphoma is an aggressive tumor with higher incidence in
Asia.Traditional CHOP/CHOP-like regiment can't produce satisfied outcome for the patients.
Asparaginase-based treatment has been demonstrated as promising response rate and survival
superiority. Stage-specified regimen may bring out exciting efficacy with good safety.